Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is botulinum toxin type A a safe and effective treatment for neurogenic urinary incontinence?

Nature Clinical Practice Urology volume 2, pages 530–531 (2005)Cite this article

boxed-textSchurch B et al. (2005) Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174: 196–200

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Schurch B et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692–697

    Article  CAS  Google Scholar 

  2. Reitz A et al. (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45: 510–515

    Article  CAS  Google Scholar 

  3. Popat R et al. (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174: 984–988

    Article  CAS  Google Scholar 

  4. Grosse J et al. (2005) Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47: 653–659

    Article  CAS  Google Scholar 

  5. Harper M et al. (2003) A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 92: 325–326

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice. The authors are supported by project grants from the British Urological Foundation (AS) and the Multiple Sclerosis Society (PD).

Author information

Authors and Affiliations

  1. Guy's Hospital and Guy's, King's and St Thomas' School of Medicine, London, UK

    Arun Sahai & Prokar Dasgupta

Author notes

  1. Arun Sahai and Prokar Dasgupta: A Sahai is a Research Fellow and P Dasgupta a Consultant Urological Surgeon and Hon. Senior Lecturer

    Authors
    1. Arun Sahai
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Prokar Dasgupta
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Prokar Dasgupta.

    Ethics declarations

    Competing interests

    The authors are co-investigators for Allergan, from whom they have received an unrestricted educational grant.

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Sahai, A., Dasgupta, P. Is botulinum toxin type A a safe and effective treatment for neurogenic urinary incontinence?. Nat Rev Urol 2, 530–531 (2005). https://doi.org/10.1038/ncpuro0329

    Download citation

    • Received:

    • Accepted:

    • Issue Date:

    • DOI: https://doi.org/10.1038/ncpuro0329

    Search

    Advanced search

    Quick links

    Nature Briefing

    Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

    Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing